BIC Governance

The General Assembly is the main decision-making body of BIC. All industry members have a seat. The General Assembly has full power of decision in order to attain and implement the Objectives of BIC. The General Assembly also elects the Board of Directors. The Board of Directors implements the general policy and the work program adopted by the General Assembly. The Board is assisted by the Programming and Public Affairs-Public Relations Working Groups. The Executive Director, heads the BIC Office and is responsible for the day-to-day management of BIC.

Governance of BIC is detailed in the BIC statutes and Internal Rules.

BIC Activities include:

  • Shaping the BBI’s Strategic Innovation and Research Agenda (SIRA)
  • Defining the annual BBI Work Plans and Call for Proposals topics
  • Mobilising industry (large, SMEs and SME clusters), research organisations, universities and relevant European stakeholders active or interested in the field of bio-based products to support innovation and the development of a long-term EU policy framework that boosts the bioeconomy
  • Improve conditions for “Access to finance” in Europe
  • Endeavour a favourable policy environment
  • Create awareness about the bioeconomy, also at national and Regional level

The General Assembly is convened by the Chairperson of the Association or Executive Director and meets at least for one ordinary meeting per year.

An Industry Member can be represented at the General Assembly by one delegate. The Associate Members may participate in the General Assembly upon specific invitation by BIC Chairperson to give their opinion, but they do not have voting right.

The General Assembly has full power of decision in order to attain and implement the Objectives of BIC. The General Assembly is competent for:

  • Decisions of a strategic nature;
  • Decisions on the Association management, activities and structure of BIC.

Chairperson
At all meetings of the General Assembly, the Chairperson of the Board of Directors acts as chairperson of the General Assembly.

Quorum and Adoption of Decisions
The General Assembly is competent to discuss and to take decisions if at least half of the Industry Members are present or represented by a proxy. The General Assembly shall strive to adopt its decisions by consensus.

BIC is managed by the Board of Directors whose members are legal entities and are elected by the General Assembly. The minimum number of Directors on the Board of Directors is 6 and the maximum number 12. The Board of Directors composition should be a balanced reflection of the composition of the Industry Members. The Board of Directors is renewed annually by half. Directors are elected by the General Assembly for a period of two years and can be reelected.

Any Director may represent BIC at the BBI JU Governing Board. The General Assembly elects, following the suggestion of the Board of Directors, a Chairperson and Vice-Chairperson(s) for a maximum period of two years.

The Board of Directors is authorised to take and execute all decisions which do not fall within the scope of powers of the General Assembly. As a result, the Board of Directors has the full scope of residual powers. The Board of Directors implements the general policy and the work program adopted by the General Assembly.

The Board of Directors meets at least twice a year and also on the initiative of the Executive Director. The Board of Directors shall strive to reach its decisions by consensus.

Mat Quaedvlieg, SAPPI
Chair

Marcel Wubbolts, Corbion

Krijn Rietveld, DSM
Vice-Chair

Giulia Gregori, Novamont

Christophe Luguel, IAR 
Vice-Chair

Agnes van Ardenne, Dutch Biorefinery Cluster

Claus Crone Fuglsang, Novozymes

Laila Rogestedt, Sodra

Niklas von Weymarn, Metsa

Camille Burel, Roquette

Stefania Pescarolo, Biochemtex

Gloria Gaupmann, Clariant 

Working Groups have been established to consider specific matters of common interest within the Objectives of the Association under the authority of the Board of Directors. The Board of Directors defines the mission statements and terms of references for each Working Group.

BIC Programming working group (PWG)

The PWG consists of all industry members and has as a prime task the development of the topics for the Annual Work Plans (AWPs). After approval by the BIC board and the BBI JU Governing Board, the AWPs will be published and a few months later launched as the annual calls of the BBI JU. A small Programming Core Team (PCT) prepares details of the topics for further discussion with the PWG. PCT membership is reviewed on an annual basis.

The PWG works with the associate members to increase the innovativeness level of the topics and ensure their ability to realise the strategic orientations of the bio-based industry in Europe.

The basis for the AWP topics is an annual Priority Paper, developed with input from industry and associate members, advisory bodies of the BBI JU and other relevant stakeholders. The topics therefore have the support and commitment of BIC’s industry members and are relevant to the bio-based industries sector as a whole.

The PWG also assists in updating the Strategic Research and Innovation Agenda (SIRA) when needed.

BIC Public Affairs & Public Relations working group (PA-PR)

The Public Affairs & Public Relations working group (PA-PR WG) outlines the advocacy and communications strategy of BIC and engages with key bioeconomy stakeholders and decision-makers, aiming for a favourable political, legal, social and economic environment for bio-based industries in Europe.

BIC focuses its attention on mainstreaming the bioeconomy concept beyond the research and innovation policy and making the initiative a political priority, advocating for a coherent, flexible and stimulating policy environment for bio-based solutions.

BIC’s advocacy, communications and partnership-building activities ensure broad participation in the BBI JU Call for Proposals and help raise awareness and grow BIC’s membership.

Responses to consultations and position papers
In January 2015, BIC submitted comprehensive answers to questions on key regulatory and investment hurdles facing the EU bio-based industries, in response to a European Commission consultation on Framework Conditions for Sectoral Research and Innovation.

Supported by the European Bioeconomy Alliance, the BIC Board also sent a letter to President Juncker and key Commissioners urging them to acknowledge the important role of the bioeconomy in delivering an ambitious European Circular Economy.

BIC drafted a Position Paper on the Circular Economy Package, which was updated in November 2015. The paper called on EU policymakers to take account of a series of recommendations in the formulation of an ambitious circular economy strategy.

BIC also prepared a Fact sheet on Biorefineries (September 2016) and a paper outlining BIC’s Views on the Waste package (October 2016), including some key policy asks: (1) Ensure access to sustainable biomass; (2) Promote industrial symbiosis and boost secondary raw materials and (3) Promote bio-based packaging.

BIC is also founding member of the European Bioeconomy Alliance (EUBA), a unique cross sector alliance dedicated to mainstreaming and realising the potential of the bioeconomy in Europe. With 11 other bioeconomy stakeholder organisations, BIC founded the European Bioeconomy Alliance (EUBA) on 4 February 2015. The European Bioeconomy Alliance focuses on advocating for a favourable and coherent policy and investment framework to build a competitive, dynamic and sustainable bioeconomy in Europe.